Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer

Neoplasma

Volumn 58, Issue 1, 2011, Pages 89-95

  Dong, S W ^a   Ma, L ^a   Xu, N ^a   Yan, H Q ^a   Liu, H Y ^a   Li, Y W ^a   Zhang, P ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

5 aza 2' deoxycytidine; Lung cancer; MSP; Promoter methylation; Syk; Tumor suppressor gene

Indexed keywords

DNA; DNA METHYLTRANSFERASE INHIBITOR; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; GENETICS; LUNG TUMOR; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; DNA METHYLATION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN-TYROSINE KINASES;

EID: 79961109914     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_01_89     Document Type: Article

References (33)

1. COOPMAN PJ, DO MTH, BARTH M, BOWDEN ET, HAYES AJ et al. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 2000; 406: 742-7. doi:10.1038/35021086
2. WANG L, DUKE L, ZHANG PS, ARLINGHAUS RB, SYMMANS WF et al. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res 2003; 63: 4724-30.
3. CHU DH, MORITA CT, WEISS A. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol. Rev, 1998; 165: 167-80. doi:10.1111/j.1600-065X.1998.tb01238.x
4. KUROSAKI T. Molecular mechanisms in B cell antigen receptor signaling. Curr Opin. Immunol, 1997, 9: 309-18. doi:10.1016/S0952-7915(97)80075-1
5. WANG S, DING YB, CHEN GY, XIA JG, WU ZY. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma[J]. World J Gast roenterol 2004; 10: 1815-8.
6. YUAN Y, WANG J, LI J, WANG L., LI M, YANG Z, ZHANG C., DAI JL. Frequent Epigenetic Inactivation of Spleen Tyrosine Kinase Gene in Human Hepatocellular Carcinoma, Clin Cancer Res, 2006 Nov 15; 12: 6687-95. doi:10.1158/1078-0432.CCR-06-0921
7. KASS SU, PRUSS D, WOLFFE AP. How does DNA methylation repress transcription? Trends Genet 1997; 13: 444-9. doi:10.1016/S0168-9525(97)01268-7
8. RAZIN A, CEDER H. DNA methylation and gene expression. Microbiol Rev 1991; 55: 451-8.
9. JONES PA, LAIRD PW. Cancer epigenetics comes of age. Nat Genet 1999; 21: 163-7. doi:10.1038/5947
10. ESTELLER M, CORN PG, BAYLIN SB, HERMAN JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225-9.
11. DING YB, WU ZY, WANG S, ZHA XM, ZHENG W, et al. Hypermethylation of Syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma. Natl Med J China 2004; 84: 290-3.
12. WANG S, DING YB, CHEN GY, XIA JG, WU ZY. Relationship between hypermethylation of Syk gene in promoter and oncogenesis, metastasis of gastric carcinoma. ACTA Universitatis Medicinalis NanJing (Natural Science) 2006; 26: 169-94.
13. GOODMAN PA, BURKHARDT N, JURAN B, TIBBLES HE, UCKUN FM. Hypermethylation of the spleen tyrosine kinase. promoter in T-lineage acute lymphoblastic leukemia [J]. Oncogene, 2003, 22(16): 2504-14. doi:10.1038/sj.onc.1206313.
14. MUSTELIN T, TASKEN K, Positive and negative regulation of T-cell activation through kinases and phosphatases, Biochem. J. 2003; 37: 15-27. doi:10.1042/BJ20021637
15. LANIER LL, Natural killer cell receptor signaling, Curr. Opin. Immunol 2003; 15: 308-14. doi:10.1016/S0952-7915(03)00039-6
16. SADA K, YAMAMURA H, Protein-tyrosine kinases and adaptor proteins in FcepsilonRI-mediated signaling in mast cells, Curr. Mol. Med 2003; 3: 85-94. doi:10.2174/1566524033361618
17. TANIGUCHI T, KOBAYASHI T, KONDO J, TAKAHASHI K, NAKAMURA H, et al. Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis[J]. J Biol Chem 1991; 266: 15790-6.
18. Tohyama Y, Yamamura H, Protein tyrosine kinase, syk: a key player in phagocytic cells. J Biochem 2009; 145: 267-73. doi:10.1093/jb/mvp001
19. MORTARINO M, GELAIN ME, GIOITA G, CIUSANI E, BAZZOCCHI B. et al. ZAP-70 and Syk expression in canine lymphoid cells and preliminary results on leukaemia cases. Vet Immunol Immunopathol 2009; 128: 395-401. doi:10.1016/j.vetimm.2008.12.010
20. BOELENS J, LUST S, VAN BOCKSTAELE F, VAN GELE M, JANSSENS A, et al. Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia. Leuk Res, 2009; 33: 1335-43. doi:10.1016/j.leukres.2009.02.022
21. GEAHLEN RL. Syk and pTyr'd: Signaling through the B cell antigen receptor. Biochim Biophys Acta, 2009; 1793: 1115-27.
22. COOPMAN PJ, MUELLER SC. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett 2006. Sep 28, 241: 159-73.
23. ULANOVA M, PUTTAGUNTA L, MARCET-PALACIOS M, DUSZYK M, STEINHOFF U, et al. Syk tyrosine kinase partici-. pates in beta1-integrin signaling and inflammatory responses. in airway epithelial cells, Am. J. Physiol. Lung Cell. Mol. Physiol 2005; 288: L497-L507. doi:10.1152/ajplung.00246.2004.
24. YAMADA T, FUJIEDA S, YANAGI S, YAMAMURA H, INATOME R, et al. Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES production, J. Immunol 2001; 166: 538-43.
25. INATOME R, YANAGI S, TAKANO S, YAMAMURA S A critical role for Syk in endothelial cell proliferation and migration, Biochem. Biophys. Res. Commun 2001; 286: 195-9. doi:10.1006/bbrc.2001.5355
26. TSUJIMURA T, YANAGIi S, INATOME R, TAKANO T, ISHIHARA I, et al. Syk protein-tyrosine kinase is involved in neuron-like differentiation of embryonal carcinoma P19 cells. FEBS Lett. 2001; Feb 2; 489: 129-33.
27. TSUCHIDA S, YANAGI S. INATOME S. DING S, HERMANN P., SUJIMURA T, et al. Purification of a 72-kDa protein-tyrosine kinase from rat liver and its identification as Syk: involvement of Syk in signaling events of hepatocytes, J. Biochem 2000; 127: 321-7.
28. HOELLER C, THALLINGER C, PRATSHER B, BISTER MD, SCHICHER N, et al. The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cells, J. Invest 2005; Dermatol 124: 1293-9.
29. TOYAMA T, IWASE H, YAMASHITA H, HARA Y, OMOTO Y, et al. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer, Cancer Lett 2003; 189: 97-102. doi:10.1016/S0304-3835(02)00463-9
30. YUAN Y, MENDEZ R, SAHIN A, DAI JL. Hypermet hylation leads to silencing of the Syk gene in human breast cancer [J]. Cancer Res 2001; 61: 5558-61.
31. YUAN Y, WANG J, LI J, WANG L, LI M, et al. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clin Cancer Res 2006; Nov 15; 12: 6687-95.
32. BUCHHOLZ TA, WAZER DE. Molecular biology and genetics ofbreast cancer development: a clinical perspective. Semin Radiat Oncol 2002; 12: 285-95. doi:10.1053/srao.2002.35248.
33. DING YB, CHEN GY, XIA JG, ZANG XW, YANG HY, YANG L. Correlation of tumor-positive ratio and number of perigastric lymph nodes with prognosis of gastric carcinoma in surgically treated patients. World J Gastroenterol 2004; 10: 182-5.